Amphastar Pharma (AMPH) Tops Q3 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2016
November 8, 2016 4:05 PM ESTReports Net Revenues of $64.2 Million for the Three Months Ended September 30, 2016
RANCHO CUCAMONGA, Calif., Nov. 08, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (Amphastar or the Company) today reported results for the three months ended September 30, 2016.
Third Quarter Highlights
Net revenues of $64.2 million for the third quarterGAAP net income of $3.9 million, or $0.08 per diluted share for the third quarterAdjusted non-GAAP net income of $6.6 million, or $0.14 per diluted share for the third... More